PRECISION
NEUROSCIENCE
Transformational therapies
OUR SCIENCE
Addressing the needs of patients with devastating and life-limiting disorders is central to our focus. Our scientific expertise in molecular mechanisms and the complex neurocircuitry underlying disorders of the nervous system is driving our development of new treatments.
ABOUT US
Engrail Therapeutics is a clinical-stage pharmaceutical company founded in 2019 with the aspiration of becoming a leader in neuroscience. We are committed to rapidly advancing our innovative, precision-targeted therapeutics.
